INOVIO COVID-19 DNA vaccine INO-4800 demonstrated robust neutralizing antibody and T cell immune responses in preclinical models
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
Llama antibody engineered to block Coronavirus
On May 19, 2020, the NIH rported that researchers from the University of Texas, in collaboration with a…
ViralClear publishesd in F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2, the cause of COVID-19
On May 14, 2020, BioSig Technologies announced that an article titled, ﾓThe IMPDH inhibitor merimepodib provided in combination…
Rice University COVID-19 research fund backed six new initiatives
On May 8, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had funded…
XBiotech identified ‘super bloods’ for development of True Human COVID-19 therapy
On May 1, 2020, XBiotech announced that human immune donors had been identified that can support the Company’s…
ViralClear submitted in vitro data on Merimepodib and Remdesivir synergistic activity against COVID-19 novel Coronavirus to peer-reviewed journal
On Apr. 30, 2020, BioSig Technologies announced that an article titled, ﾓThe IMPDH inhibitor merimepodib provided in combination…
Texas A&M researchers lead testing of tuberculosis vaccine to fight COVID-19
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
ViralClear published comparative in vitro data on merimepodib and remdesivir activity against COVID-19 novel Coronavirus in F1000 research
On Apr. 23, 2020, BioSig Technologies announced that an article titled, ﾓThe IMPDH inhibitor merimepodib has similar antiviral…
Bellicum completed sale of Houston facility to MD Anderson for $15 million
On Apr. 15, 2020, Bellicum Pharma announced closing of the sale of its Houston facility to The University…
Positive data generated by Biosig subsidiary ViralClear on Covid-19 Coronavirus published in bioRxiv
On Apr. 9, 2020, BioSig Technologies announced that an article titled “The IMPDH inhibitor merimepodib suppresses SARS-COV-2 replications”…
Texas A&M Researchers designed 3D-printed diffuser to treat COVID-19 patients
On Apr. 8, 2020, a team of Texas A&M University researchers led by Michael R. Moreno, in collaboration…
VGXI established pilot mRNA manufacturing capabilities
On Apr. 6, 2020, VGX announced successful implementation of new RNA production services through completion of all Phase…
Fred Hutch team launched hunt for coronavirus antibodies
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
Sorrento announced research testing agreement with University of Texas for preclinical testing of COVID-19 therapeutic product candidates
On Mar. 31, 2020, Sorrento announced it had entered into a research testing agreement with The University of…
Amneal Pharmaceuticals donated hydroxychloroquine sulfate to state of Texas
On Mar. 26, 2020, Amneal Pharma announced it had donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State…
iBio announced advancement of COVID-19 vaccine program
On Mar. 26, 2020, iBio announced that immunization studies for its SARS-CoV-2 Virus-Like Particle program (‘IBIO-200’) were proceeding…
iBio supporting AzarGen Biotechnologies’ development of a Rituximab biosimilar at Bryan, Texas facility
On Mar. 26, 2020, iBio announced that it had entered into a development agreement with AzarGen Biotechnologies. Signed…
Texas Biomed established team to study SARS-CoV-2, new coronavirus
On Feb. 24, 2020, Scientists at Texas Biomed began work on the novel coronavirus known as SARS-CoV-2. A…
NIH scientists identified atomic structure of novel Coronavirus protein
On Feb. 19, 2020, NIAID scientists working with investigators from the University of Texas at Austin identified the…
The Cancer Prevention and Research Institute of Texas announced it had recruited its 200th CPRIT scholar
On Jan. 27, 2020, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had recruited its…
The Cancer Prevention and Research Institute of Texas awarded 10 new recruitment grants
On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 10 new recruitment grants,…
IRBM signed agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies
On Sept. 9, 2019, IRBM announced the signing of a service and development agreement with The University of…
CPRIT granted $18.7 million New Company Product Development award to Salarius Pharmaceuticals
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
The Cancer Prevention and Research Institute of Texas awarded a relocation grant to Hummingbird Bioscience
On Jun. 4, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $13 million relocation…
The Cancer Prevention and Research Institute of Texas announced the formation of the 2018 Texas Cancer Plan
On Sept. 25, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the formation of the…
The CPRIT established the Collaborative Action Program for Liver Cancer
On Aug. 29, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it would invest up…
The Cancer Prevention and Research Institute of Texas announced surpassed $2 billion in grants to fight cancer
On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…
Texas Life Science Genealogy, 2018
Texas Life Science Genealogy illustrates life science companies and non-profit research organization in the State of Texas by…
CPRIT announced a new Early Translational Research Award to combat cancer
On May 31, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a new Early Translational…
The CPRIT announced a Seed Award for early-stage oncology startup companies
On Apr. 30, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a Seed Award for…